Close

Progenra deploys Dotmatics drug research platform

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

McKesson Acquires Controlling Stake in PRISM Vision

McKesson Corporation has announced its agreement to acquire a...

CluePoints Launches Medical & Safety Review (MSR) Software to Revolutionize Clinical Data Review

CluePoints continues to transform clinical trial review and leverage its...

ML And AI Transforming Pharmaceutical R&D And Drug Discovery

Richard Lee, Director, Core Technology and Capabilities, ACD/Labs, says...

TraceLink’s Magnum Release of Platform for Supply Chain Management

TraceLink, the largest end-to-end digital network platform for intelligent...

Progenra, a biotechnology company, has selected Dotmatics’ suite of scientific informatics solutions to enhance its drug research and development process.

The Dotmatics platform is a fully optimized suite of programs designed to make research data readily accessible and useful.

The company’s suite of solutions are used to manage and analyze the critical scientific data which allows users to integrate and view complex research data from disparate sources.

Progenra Business Development senior director Marc Hixson said, “Having evaluated other solutions, Progenra replaced legacy CambridgeSoft tools with the Dotmatics platform because of the seamless interface and ease of use which has allowed Progenra to effectively and efficiently manage their internal and external programs.”

Dotmatics is a scientific software company deploying web-based knowledge solutions that dramatically improve the way scientific data is queried, managed and shared within companies.

Latest stories